Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Patients submitted to noncardiac surgeries are at increased risk of serious cardiovascular
complications. Statins have shown to lower cholesterol levels and reduce cardiovascular
events in other scenarios. The objective of this study is to explore the effects of
atorvastatin, as compared with placebo, on the 30-day risk of a composite of death, nonfatal
Myocardial Injury after Noncardiac Surgery (MINS), or stroke among patients who undergo
noncardiac surgery.